Riskpilot← Back to searchSign inGet full accessBALDERKLINIKKEN AS
ASActiveOrg 988409197Munchs gate 7, 0165 OsloOther human health activities n.e.c. · NACE 8699Est. 20057 employeeswww.balderklinikken.no
Revenue 2024
NOK 20,9M
+1% vs 2023
EBITDA margin
4.1%
+263% vs 2023
Equity ratio
-121.0%
Financial strength
Net profit 2024
NOK 545K
+1580% vs 2023
| Revenue | NOK 20,9M | +1% |
| EBITDA | NOK 853K | +263% |
| Net profit | NOK 545K | +1580% |
| Total assets | NOK 1,5M | +4% |
| Equity | NOK -1,9M | +23% |
| Employees | 7 | — |
Legal name
BALDERKLINIKKEN AS
Org number
988409197
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
4. juli 2005
Share capital
NOK 131 551
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Medisinske tjenester, konsulentvirksomhet og deltagelse i andre virksomheter.
Address
Munchs gate 7, 0165 Oslo
Website
www.balderklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 21 010 | 18 776 | 21 264 | 20 650 | 20 944 |
| Staff expenses | −3 511 | −3 401 | −3 654 | −3 004 | −2 743 |
| EBITDA | 471 | −857 | −40 | 235 | 853 |
| Depreciation & amort. | −133 | −88 | −89 | −63 | −63 |
| EBIT | 338 | −945 | −129 | 172 | 790 |
| Net financials | −99 | −173 | −103 | −140 | −246 |
| Profit before tax | 239 | −1 118 | −233 | 32 | 545 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 239 | −1 118 | −233 | 32 | 545 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 808 | 1 780 | 1 601 | 1 486 | 1 542 |
| Equity | −1 093 | −2 211 | −2 443 | −2 411 | −1 866 |
| Long-term debt | 1 037 | 1 931 | 1 839 | 1 871 | 1 470 |
| Short-term debt | 1 864 | 2 060 | 2 205 | 2 026 | 1 938 |
| Total debt | 2 901 | 3 991 | 4 044 | 3 897 | 3 408 |
EBITDA margin
4.1%
This company
15.8%
Market median
-74% vs market
20202024
Equity ratio
-121.0%
This company
38.2%
Market median
-417% vs market
20202024
Return on equity
54468900.0%
This company
18.4%
Market median
+296026530% vs market
20202024
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20202024
Asset turnover
13.58×
This company
1.12×
Market median
+1113% vs market
20202024
Debt / equity
1.83×
This company
0.62×
Market median
-195% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BT Chief Executive Officer | Chief Executive Officer | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2017 | |
| Board of Directors | 2017 | |
| Chairman | 2017 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 72.22% | 72.22% | 2024 | |
| Individual | 5.7% | 5.7% | 2024 | |
| Individual | 3.8% | 3.8% | 2024 | |
| Individual | 3.8% | 3.8% | 2024 | |
| Individual | 3.04% | 3.04% | 2024 | |
| Individual | 2.06% | 2.06% | 2024 | |
| Individual | 1.9% | 1.9% | 2024 | |
| Individual | 1.9% | 1.9% | 2024 | |
| Individual | 1.9% | 1.9% | 2024 | |
| Company | 1.9% | 1.9% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BALDERKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bernt Tore Rognlien | Chief Executive Officer | 0 companies |
| Anne Stensløkken | Board of Directors | 0 companies |
| Ivar Steen-Johnsen | Board of Directors | 0 companies |
| Odd Einar Rustad Nilssen | Chairman | 0 companies |